Gary V. Cantrell
Corporate Officer/Principal en North Carolina State University .
Fortuna: 23 299 $ al 30/04/2024
Perfil
Gary V.
Cantrell currently works at North Carolina State University, as Principal and Averaden LLC, as Principal from 2015.
Mr. Cantrell also formerly worked at Yasoo Health, Inc., as Chief Executive Officer from 2007 to 2015, Vyrix Pharmaceuticals, Inc., as Independent Director from 2014 to 2015, GlaxoSmithKline, Inc., as Group Director-Non Promoted Brands, Flexible Stenting Solutions, Inc., as Director from 2008 to 2013, Yasoo Health Ltd., as Director, Aytu Biopharma, Inc., as Independent Director from 2016 to 2022, Accentia Biopharmaceuticals, Inc., as Executive Vice President-Sales & Marketing, TEAMM Pharmaceuticals, Inc., as Executive Vice President-Sales & Marketing from 2001 to 2006, and The Catevo Group, Inc., as President from 2006 to 2007.
Mr. Cantrell received his undergraduate degree from Wichita State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AYTU BIOPHARMA, INC.
0.15% | 21/12/2022 | 8 204 ( 0.15% ) | 23 299 $ | 30/04/2024 |
Cargos activos de Gary V. Cantrell
| Empresas | Cargo | Inicio |
|---|---|---|
| North Carolina State University | Corporate Officer/Principal | - |
| Averaden LLC | Corporate Officer/Principal | 01/06/2015 |
Antiguos cargos conocidos de Gary V. Cantrell.
| Empresas | Cargo | Fin |
|---|---|---|
| AYTU BIOPHARMA, INC. | Director/Miembro de la Junta | 31/12/2022 |
Vyrix Pharmaceuticals, Inc.
 Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | Director/Miembro de la Junta | 01/04/2015 |
| Yasoo Health, Inc. | Director Ejecutivo | 01/01/2015 |
Flexible Stenting Solutions, Inc.
 Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Flexible Stenting Solutions, Inc. manufactures and distributes medical devices. It develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. The company was founded by Janet W. Burpee in 2006 and is headquartered in Eatontown, NJ. | Director/Miembro de la Junta | 01/03/2013 |
The Catevo Group, Inc.
 The Catevo Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Catevo Group, Inc. provided business consulting services. It offered strategic marketing, integrated communications, consulting and technology solutions. The company was founded in 2006 and was headquartered in Raleigh, NC. | Presidente | 01/06/2007 |
Formación de Gary V. Cantrell.
| Wichita State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 9 |
|---|---|
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
Vyrix Pharmaceuticals, Inc.
Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | Health Technology |
TEAMM Pharmaceuticals, Inc.
 TEAMM Pharmaceuticals, Inc. Medical DistributorsDistribution Services TEAMM Pharmaceuticals, Inc. engaged in the business of selling prescription based pharmaceutical products. The company was headquartered in Morrisville, NC. | Distribution Services |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
The Catevo Group, Inc.
The Catevo Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Catevo Group, Inc. provided business consulting services. It offered strategic marketing, integrated communications, consulting and technology solutions. The company was founded in 2006 and was headquartered in Raleigh, NC. | Commercial Services |
Flexible Stenting Solutions, Inc.
Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Flexible Stenting Solutions, Inc. manufactures and distributes medical devices. It develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. The company was founded by Janet W. Burpee in 2006 and is headquartered in Eatontown, NJ. | Health Services |
| Yasoo Health, Inc. | |
| Yasoo Health Ltd. | |
| Averaden LLC |
- Bolsa de valores
- Insiders
- Gary V. Cantrell
